Basel-based medtech company Medartis has acquired Mimedis, a Swiss medical device start-up company. Mimedis uses 3D printing to manufacture patient specific implants and templates.
With effect of 05.07.2017, Medartis has acquired 100% ownership of Mimedis AG, a Swiss medical device start-up company located in Basel. As a result of this acquisition, Medartis will in future be able to offer preoperative planning solutions as well as patient specific implants. The parties have agreed not to disclose financial terms and other conditions of the transaction.
Mimedis focuses on patient specific solutions, especially for cranio-maxillofacial surgery. Based on an in-house developed innovative software, Mimedis supports various hospitals in Switzerland and Germany with preoperative planning as well as manufacturing of 3D models for individualized surgical treatment solutions, e.g. bone implants or cutting and drill guide templates. Mimedis is the first successful start-up company resulting from the cooperation of the School of Life Sciences at the University of Applied Sciences and Arts Northwestern Switzerland (FHNW) and the University Hospital Basel.
For Mimedis, the merger is an opportunity to make the Mimedis technologies accessible to a broader market. Ralf Schumacher, CEO of Mimedis: «The extensive market presence of Medartis and the integration of our digital product range will allow for a larger number of patients to benefit from individualized implant solutions.»
Willi Miesch, CEO of Medartis: «The progressive digitalization modifies also medical treatment. Thus, preoperative planning for surgery is becoming increasingly relevant. Mimedis’ planning software ideally complements Medartis’ product portfolio. This includes both planning of complex interventions with our craniofacial MODUS implants as well as patient specific implants not included in the standard portfolio.»
About Medartis
Founded in 1997 and headquartered in Basel, Medartis AG is one of the world’s leading manufacturers and providers of medical devices for surgical fixation of bone fractures and osteotomies for the craniofacial region as well as for upper and lower extremities. In 2016, Medartis employed over 360 people worldwide and achieved a turnover of almost CHF 100 Mio. Medartis is represented worldwide in ten markets with its own sales force and in over 35 countries through a broad distributor network. For patients’ welfare, Medartis is committed to providing surgeons and operating theatre personnel with most innovative titanium implants and instruments as well as best in class services that represent advances in osteosynthesis.
Please login or sign up to comment.
Commenting guidelines